The FDA has issued an alert that repackaged intravitreal injections of the drug Avastin have caused at least a dozen serious eye infections in the Miami area, according to an FDA news release.
The Florida Department of Health notified the FDA of a cluster of streptococcus endophthalmitis infections in three clinics, following intravitreal injection of the repackaged Avastin.
The tainted injections were traced to a pharmacy in Hollywood, Fla.
Related Articles on FDA Alerts:
FDA Warns Healthcare Professionals to Stop Using Claris IV Bags
Hospira Expands Recall of Propofol and Liposyn
Commentary on Safety Concerns Regarding Fresenius Propofol From Anesthesiologist Daniel Van Riper